| Literature DB >> 33278182 |
Kyle N Kunze1, Michelle Richardson, David N Bernstein, Ajay Premkumar, Nicolas S Piuzzi, Alexander S McLawhorn.
Abstract
INTRODUCTION: The Altmetric Attention Score (AAS) has been associated with citation rates across medical and surgical disciplines. However, factors that drive high AAS remain poorly understood and there remains multiple pitfalls to correlating these metrics alone with the quality of a study. The purpose of the current study was to determine the relationship between methodologic and study biases and the AAS in randomized controlled trials (RCTs) published in total joint arthroplasty journals.Entities:
Mesh:
Year: 2020 PMID: 33278182 PMCID: PMC7714052 DOI: 10.5435/JAAOSGlobal-D-20-00187
Source DB: PubMed Journal: J Am Acad Orthop Surg Glob Res Rev ISSN: 2474-7661
Cochrane Risk of Bias Tool and Descriptions
| Bias Domain | Bias Source | Description | High Risk | Low Risk | Unclear Risk |
| Attrition | Incomplete outcome data | Described the completeness of outcome data for each main outcome, including attrition and exclusions from the analysis. Stated whether attrition and exclusions were reported, the numbers in each intervention group (compared with total randomized participants), reasons for attrition/exclusions where reported. | Attrition bias because of amount, nature or handling of incomplete outcome data | Handling of incomplete outcome data was complete and unlikely to have produced bias | Insufficient reporting of attrition/exclusions to permit judgment of “low risk” or “high risk” (eg, number randomized not stated, no reasons for missing data provided) |
| Detection | Blinding of outcome assessment | Described all measures used, if any, to blind outcome assessors from knowledge of which intervention a participant received. Provided any information relating to whether the intended blinding was effective. | Detection bias because of knowledge of the allocated interventions by outcome assessors. | Blinding was likely effective | Not described in sufficient detail |
| Performance | Blinding of participants and personnel | Described all measures used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Provided any information relating to whether the intended blinding was effective | Performance bias because of knowledge of the allocated interventions by participants and personnel during the study. | Blinding was likely effective. | Not described in sufficient detail |
| Reporting | Selective reporting | Stated how the possibility of selective outcome reporting was examined by the authors and what was found. | Reporting bias because of selective outcome reporting. | Selective outcome reporting bias not detected | Insufficient information to permit judgment (it is likely that most studies will fall into this category) |
| Selection | Random sequence generation | Described the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. | Selection bias (biased allocation to interventions) because of inadequate concealment of allocations before assignment. | Random sequence generation method should produce comparable groups | Not described in sufficient detail |
| Allocation concealment | Described the method used to conceal the allocation sequence in sufficient detail to determine whether intervention allocations could have been foreseen in advance of, or during, enrollment. | Selection bias (biased allocation to interventions) because of inadequate concealment of allocations before assignment. | Intervention allocations likely could not have been foreseen in advance of, or during, enrollment | Not described in sufficient detail | |
| Other | Any other bias, ideally prespecified | Any important concerns about bias not addressed above. If particular questions/entries were prespecified in the study's protocol, responses should be provided for each question/entry. | Bias because of complications not covered elsewhere in the table. | No other bias detected | There may be a risk of bias, but there is either insufficient information to assess whether an important risk of bias exists; or insufficient rationale or evidence that an identified complications will introduce bias. |
Baseline Study Characteristics Including Bibliometric and Altmetric Variables
| Characteristic | Journal | |||||||
| BJJ (n = 7) | JBJS (n = 7) | CORR (n = 8) | JOA (n = 9) | JKS (n = 2) | Hip Int. (n = 3) | Acta (n = 6) | ||
| Author degree | 0.53 | |||||||
| MD/DO | 1 (14.3) | 4 (57.1) | 4 (50) | 4 (44.4) | 2 (100) | 3 (100) | 2 (33.3) | |
| Other | ||||||||
| Continent | ||||||||
| North America | 1 (14.3) | 0 (0) | 5 (62.5) | 2 (22.2) | 2 (100) | 0 (0) | 0 (0) | |
| Europe | 4 (57.1) | 5 (71.4) | 2 (25) | 2 (22.2) | 0 (0) | 0 (0) | 6 (100) | |
| Asia | 1 (14.3) | 1 (14.3) | 1 (12.5) | 2 (22.2) | 0 (0) | 3 (100) | 0 (0) | |
| South America | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Africa | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Australia | 1 (14.3) | 1 (14.3) | 0 (0) | 3 (33.3) | 0 (0) | 0 (0) | 0 (0) | |
| COI | ||||||||
| Yes | 5 (71.4) | 1 (14.3) | 5 (62.5) | 2 (22.2) | 2 (100) | 3 (100) | 6 (100) | |
| No/not stated | ||||||||
| Joint studied | 0.29 | |||||||
| Hip | 1 (14.3) | 3 (42.9) | 2 (25) | 5 (55.6) | 0 (0) | 3 (100) | 3 (50) | |
| Knee | 6 (85.7) | 4 (57.1) | 6 (75) | 3 (33.3) | 2 (100) | 0 (0) | 3 (50) | |
| Both | 0 (0) | 0 (0) | 0 (0) | 1 (11.1) | 0 (0) | 0 (0) | 0 (0) | |
| Arthroplasty | ||||||||
| Primary | 6 (85.7) | 5 (71.4) | 7 (87.5) | 7 (77.8) | 0 (0) | 3 (100) | 6 (100) | |
| Revision | 1 (14.3) | 1 (14.3) | 0 (0) | 2 (22.2) | 0 (0) | 0 (0) | 0 (0) | |
| Hemiarthroplasty | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Resurfacing | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Infection (one or two-stage exchange) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Mega-prosthesis (non-oncologic) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Unicompartmental | 0 (0) | 1 (14.3) | 1 (12.5) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Multiple/other | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (100) | 0 (0) | 0 (0) | |
| Topic | ||||||||
| Clinical/survivorship | 5 (71.4) | 5 (71.4) | 6 (75) | 8 (88.9) | 1 (50) | 3 (100) | 2 (33.3) | |
| Imaging-based | 2 (28.6) | 2 (28.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Preclinical | 0 (0) | 0 (0) | 1 (12.5) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Implant design | 0 (0) | 0 (0) | 0 (0) | 1 (11.1) | 0 (0) | 0 (0) | 4 (66.7) | |
| Cost-analysis/economics/health policy | 0 (0) | 0 (0) | 1 (12.5) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Epidemiology | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Measure development/validation | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Kinematics/gait | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | |
| Other | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| No. of authors | 6.3 ± 1.8 | 4.9 ± 1.6 | 5 ± 1.9 | 5.9 ± 1.3 | 6.5 ± 0.7 | 6.0 ± 1.0 | 5.3 ± 1.8 | 0.53 |
| No. of institutions | 2.4 ± 1.4 | 1.4 ± 0.8 | 1.6 ± 1.0 | 1.7 ± 0.87 | 3.5 ± 0.7 | 1.0 ± 0.0 | 2.3 ± 1.2 | 0.08 |
| No. of references | 33.9 ± 6.0 | 31.0 ± 7.9 | 33.1 ± 15.2 | 25 ± 6.3 | 18 ± 4.2 | 26.7 ± 4.5 | 28.2 ± 6.5 | 0.20 |
| Sample size | 118.0 ± 71.5 | 84.7 ± 45.6 | 142.1 ± 163.6 | 178.3 ± 320.1 | 53 ± 24.0 | 124.0 ± 76.9 | 48.8 ± 16.4 | 0.84 |
| Citations | 17.9 ± 12.8 | 38.1 ± 29.6 | 19.3 ± 16.3 | 13.7 ± 12.3 | 6.5 ± 0.7 | 7.7 ± 11.6 | 6.8 ± 3.5 | |
| AAS | 19.6 ± 25.4 | 13.3 ± 22.5 | 7.5 ± 3.6 | 4.6 ± 10.3 | 1.5 ± 0.7 | 0.7 ± 1.2 | 0.2 ± 0.4 | 0.25 |
| Twitter mentions | 7 (100) | 5 (71.4) | 8 (100) | 7 (77.8) | 2 (100) | 1 (33.3) | 1 (16.7) | |
| Facebook mentions | 7 (100) | 2 (28.6) | 8 (100) | 0 (0) | 1 (50) | 1 (33.3) | 0 (0) | |
| News outlet mentions | 0 (0) | 1 (14.3) | 0 (0) | 1 (11.1) | 0 (0) | 0 (0) | 0 (0) | 0.74 |
| Blog mentions | 0 (0) | 4 (57.1) | 0 (0) | 1 (11.1) | 0 (0) | 0 (0) | 0 (0) | |
| Mendeley reads | 45.9 ± 18.2 | 57.1 ± 20.0 | 69.4 ± 28.3 | 40.1 ± 14.5 | 56.5 ± 3.5 | 9.3 ± 16.2 | 16.2 ± 39.6 | |
| Wikipedia mentions | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — |
AAS = Altmetric Attention Score, Acta = Acta Orthopaedica, BJJ = The Bone and Joint Journal, CORR = Clinical Orthopaedics and Related Research, Hip Int. = Hip International, JBJS = The Journal of Bone and Joint Surgery, JKS = The Journal of Knee Surgery, JOA = The Journal of Arthroplasty
Statistics reported as frequencies (percentages) or mean ± SD. Bolded P values indicated statistical significance at P < 0.05 level.
Figure 1Linear regression model demonstrating relationship between the JADAD methodological quality score for RCTs versus the AAS for RCTs in seven total joint arthroplasty journals. AAS = Altmetric Attention Score, CI = confidence interval, RCT = randomized controlled trial
Figure 2Linear regression model demonstrating relationship between the total number of study biases for RCTs versus the AAS for RCTs in seven total joint arthroplasty journals. AAS = Altmetric Attention Score, CI = confidence interval, RCT = randomized controlled trial
Figure 3Linear regression model demonstrating relationship between AAS RCTs versus the citation rate for RCTs in seven total joint arthroplasty journals. AAS = Altmetric Attention Score, CI = confidence interval, RCT = randomized controlled trial.